Insider track record
OtherAcross 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by CODE KENNETH REAY. Director active across 1 company, notably Biolargo, INC.. In total, 12 filings have been recorded. Activity tracked since 5 October 2021. The latest transaction was disclosed on 7 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
532,567 shares@ US$0.11350.17% mcap28.6% of flowCommon StockSEC:0001437749-26-022951:0
69,444 shares@ US$0.1625.0% of flowCommon StockSEC:0001437749-26-011170:0
181,253 shares@ US$0.2014.6% of flowCommon StockSEC:0001437749-25-022850:0
57,666 shares@ US$0.198.0% of flowCommon stockSEC:0001437749-25-000351:0
72,621 shares@ US$0.1688.4% of flowCommon stockSEC:0001437749-24-000496:0
19,010 shares@ US$0.16572.3% of flowCommon stockSEC:0001437749-23-027572:0
68,541 shares@ US$0.1788.5% of flowCommon stockSEC:0001437749-23-019410:0
30,747 shares@ US$0.20494.4% of flowCommon stockSEC:0001437749-23-009344:0
167,781 shares@ US$0.2734.9% of flowCommon stockSEC:0001437749-22-023721:0
107,784 shares@ US$0.1814.0% of flowCommon stockSEC:0001437749-22-016650:0
15,000 shares@ US$0.210.0048% mcap10.8% of flowCommon stockSEC:0001437749-22-000330:0
61,842 shares@ US$0.190.017% mcap39.2% of flowCommon stockSEC:0001437749-21-023395:0
About CODE KENNETH REAY
CODE KENNETH REAY is Chief Science Officer at Biolargo, INC. The declarant has 11 filings in total. Among the sampled recent filings, the period runs from 2021-10-06 to 2025-01-03, with transactions of the Attribution type and buy and sell amounts shown as 0.